Compare
Candriam Eq. L Biotechnology C $ LU0108459040
Asset allocation
| Foreign stocks | 97.49% |
| Other | 2.51% |
| Total NAV | 448.98 mln (United States Dollar) |
Update date: 4/30/2026
Currency allocation
| United States Dollar | 91.90% |
| Euro | 2.75% |
| Non definito | 2.51% |
| Danish Krone | 2.41% |
| Swiss Franc | 0.44% |
Update date: 4/30/2026
Geographical allocation
| North America | 82.11% |
| Europe | 14.87% |
| World / Multiple areas | 2.51% |
| Africa, Arabic Area, Middle East | 0.50% |
Update date: 4/30/2026
Sector allocation
| Health Care | 93.62% |
| Not Available | 2.51% |
| MATERIALS & COMMODITIES | 1.82% |
| INDUSTRIALS | 1.12% |
| FINANCIALS | 0.50% |
| Consumer Staples | 0.44% |
Update date: 4/30/2026
Top Ten holdings
| VERTEX PHARMACEUTICALS INC | 4.01% |
| GILEAD SCIENCES INC | 3.93% |
| ALNYLAM PHARMACEUTICALS INC | 3.83% |
| AMGEN INC | 3.75% |
| REGENERON PHARMACEUTICALS | 3.48% |
| BIOGEN INC | 3.41% |
| INSMED INC | 3.02% |
| REVOLUTION MEDICINES INC | 2.86% |
| ROIVANT SCIENCES LTD | 2.77% |
| ASCENDIS PHARMA A/S | 2.29% |
Update date: 4/30/2026